Early Neurodevelopmental Outcomes in Pediatric Congenital Heart Disease
-
By
-
Andrea Surnit
-
June 2, 2026
-
3 min
By
Andrea Surnit
June 2, 2026
by Andrea Surnit
June 2, 2026
Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.
May 14, 2026
Review summarizes pharmacokinetic and clinical data on iron protein succinylate across patients with iron deficiency and iron deficiency anemia.
May 19, 2026
In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.
May 27, 2026